P. Anglade, S. Vyas, F. Javoy-agid, M. T. Herrero, P. P. Michel et al., Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. Histopathol, vol.12, pp.25-31, 1997.

W. Dauer and S. Przedborski, Parkinson's disease: mechanisms and models, Neuron, vol.39, pp.889-909, 2003.

H. Katsuki, C. Takenaka, T. Kume, S. Kaneko, A. et al., Requirement of neural activity for the maintenance of dopaminergic neurons in rat midbrain slice cultures, Neurosci. Lett, vol.300, pp.166-170, 2001.

P. P. Michel, D. Alvarez-fischer, S. Guerreiro, A. Hild, A. Hartmann et al., Role of activity-dependent mechanisms in the control of dopaminergic neuron survival, J. Neurochem, vol.101, pp.289-297, 2007.

H. Neuhoff, A. Neu, B. Liss, and J. Roeper, 2002) I h channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain, J. Neurosci, vol.22, pp.1290-1302

K. Nagamoto-combs, K. M. Piech, J. A. Best, B. Sun, and A. W. Tank, Tyrosine hydroxylase gene promoter activity is regulated by both cyclic AMP-responsive element and AP1 sites following calcium influx. Evidence for cyclicAMP-responsive element binding protein-independent regulation, J. Biol. Chem, vol.272, pp.6051-6058, 1997.

E. Hirsch, A. M. Graybiel, and Y. A. Agid, Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease, Nature, vol.334, pp.345-348, 1988.

B. Liss, O. Haeckel, J. Wildmann, T. Miki, S. Seino et al., K ATP channels promote the differential degeneration of dopaminergic midbrain neurons, Nat. Neurosci, vol.8, pp.1742-1751, 2005.

A. Sato, Y. Arimura, Y. Manago, K. Nishikawa, K. Aoki et al., Parkin potentiates ATP-induced currents due to activation of P 2X receptors in PC12 cells, J. Cell. Physiol, vol.209, pp.172-182, 2006.

M. Quik, M. O'neill, and X. A. Perez, Nicotine neuroprotection against nigrostriatal damage: importance of the animal model, Trends Pharmacol. Sci, vol.28, pp.229-235, 2007.

U. Maskos, Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors, J. Neurochem, vol.114, pp.641-646, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01573866

C. Karachi, D. Grabli, F. A. Bernard, D. Tandé, N. Wattiez et al., Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease, J. Clin. Invest, vol.120, pp.2745-2754, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00795787

E. L. Thacker, E. J. O'reilly, M. G. Weisskopf, H. Chen, M. A. Schwarzschild et al., Temporal relationship between cigarette smoking and risk of Parkinson disease, Neurology, vol.68, pp.764-768, 2007.

D. Lau, L. M. Breteler, and M. M. , Epidemiology of Parkinson's disease, Lancet Neurol, vol.5, pp.525-535, 2006.

B. Salthun-lassalle, E. C. Hirsch, J. Wolfart, M. Ruberg, and P. P. Michel, Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels, J. Neurosci, vol.24, pp.5922-5930, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00325266

P. P. Michel, M. Ruberg, A. , and Y. , Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside, J. Neurochem, vol.69, pp.1499-1507, 1997.

S. Guerreiro, D. Toulorge, E. Hirsch, M. Marien, P. Sokoloff et al., Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels, Mol. Pharmacol, vol.74, pp.980-989, 2008.

S. Traver, M. Marien, E. Martin, E. C. Hirsch, and P. P. Michel, The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway, Mol. Pharmacol, vol.70, pp.30-40, 2006.

S. W. Halvorsen and D. K. Berg, Identification of a nicotinic acetylcholine receptor on neurons using an alpha-neurotoxin that blocks receptor function, J. Neurosci, vol.6, pp.3405-3412, 1986.

D. Toulorge, S. Guerreiro, E. C. Hirsch, and P. P. Michel, K ATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis, J. Neurochem, vol.114, pp.553-564, 2010.

H. Tsuneki, R. Klink, C. Léna, H. Korn, and J. P. Changeux, Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta, Eur. J. Neurosci, vol.12, pp.2475-2485, 2000.

J. H. Lee, J. C. Gomora, L. L. Cribbs, and E. Perez-reyes, Nickel block of three cloned T-type calcium channels: low concentrations selectively block ?1H, Biophys. J, vol.77, pp.3034-3042, 1999.

A. Douhou, J. D. Troadec, M. Ruberg, R. Raisman-vozari, and P. P. Michel, Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K ? requires concurrent inactivation of NMDA or AMPA/kainate receptors, J. Neurochem, vol.78, pp.163-174, 2001.

P. M. Radcliffe, C. R. Sterling, and A. W. Tank, Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone, J. Neurochem, vol.109, pp.1272-1284, 2009.

N. P. Visanji, M. J. O'neill, and S. Duty, Nicotine, but neither the ?4?2 ligand RJR2403 nor an ?7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle, Neuropharmacology, vol.51, pp.506-516, 2006.

J. A. Abin-carriquiry, G. Costa, J. Urbanavicius, B. K. Cassels, M. Rebolledo-fuentes et al., In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's disease, Eur. J. Pharmacol, vol.589, pp.80-84, 2008.

M. Khwaja, A. Mccormack, J. M. Mcintosh, D. A. Di-monte, and M. Quik, Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to ?6?2 nAChRs, J. Neurochem, vol.100, pp.180-190, 2007.

P. D. Livingstone and S. Wonnacott, Nicotinic acetylcholine receptors and the ascending dopamine pathways, Biochem. Pharmacol, vol.78, pp.744-755, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00509505

T. J. Turner, Nicotine enhancement of dopamine release by a calcium-dependent increase in the size of the readily releasable pool of synaptic vesicles, J. Neurosci, vol.24, pp.11328-11336, 2004.

G. L. Forster and C. D. Blaha, Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat, Eur. J. Neurosci, vol.17, pp.751-762, 2003.

Q. S. Liu and D. K. Berg, Extracellular calcium regulates responses of both ?3-and ?7-containing nicotinic receptors on chick ciliary ganglion neurons, J. Neurophysiol, vol.82, pp.1124-1132, 1999.

M. Marinelli and F. J. White, Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons, J. Neurosci, vol.20, pp.8876-8885, 2000.

A. Dagher and T. W. Robbins, Personality, addiction, dopamine: insights from Parkinson's disease, Neuron, vol.61, pp.502-510, 2009.

F. Yang, L. Feng, F. Zheng, S. W. Johnson, J. Du et al., GDNF acutely modulates excitability and A-type K ? channels in midbrain dopaminergic neurons, Nat. Neurosci, vol.4, pp.1071-1078, 2001.

J. L. Joyal, D. J. Burks, S. Pons, W. F. Matter, C. J. Vlahos et al., Calmodulin activates phosphatidylinositol 3-kinase, J. Biol. Chem, vol.272, pp.28183-28186, 1997.

V. Ries, C. Henchcliffe, T. Kareva, M. Rzhetskaya, R. Bland et al., Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.18757-18762, 2006.

H. Kawai, W. Zago, and D. K. Berg, Nicotinic ?7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins, J. Neurosci, vol.22, pp.7903-7912, 2002.

J. P. Changeux and S. J. Edelstein, Allosteric receptors after 30 years, Neuron, vol.21, pp.959-980, 1998.

D. P. Darcy and J. S. Isaacson, L-type calcium channels govern calcium signaling in migrating newborn neurons in the postnatal olfactory bulb, J. Neurosci, vol.29, pp.2510-2518, 2009.